These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 25940580)
1. Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era. van der Linden M; Perniciaro S; Imöhl M BMC Infect Dis; 2015 May; 15():207. PubMed ID: 25940580 [TBL] [Abstract][Full Text] [Related]
2. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014. Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268 [TBL] [Abstract][Full Text] [Related]
3. Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany. van der Linden M; Falkenhorst G; Perniciaro S; Imöhl M PLoS One; 2015; 10(7):e0131494. PubMed ID: 26132078 [TBL] [Abstract][Full Text] [Related]
4. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children. van der Linden M; Reinert RR; Kern WV; Imöhl M BMC Infect Dis; 2013 Feb; 13():70. PubMed ID: 23384407 [TBL] [Abstract][Full Text] [Related]
6. Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015. Kaur R; Casey JR; Pichichero ME Pediatr Infect Dis J; 2016 Aug; 35(8):901-6. PubMed ID: 27420806 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility and clonality of Streptococcus pneumoniae isolates recovered from invasive disease cases during a period with changes in pneumococcal childhood vaccination, Norway, 2004-2016. Siira L; Vestrheim DF; Winje BA; Caugant DA; Steens A Vaccine; 2020 Jul; 38(34):5454-5463. PubMed ID: 32616324 [TBL] [Abstract][Full Text] [Related]
8. Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13. Redin A; Ciruela P; de Sevilla MF; Gomez-Bertomeu F; Gonzalez-Peris S; Benitez MA; Trujillo G; Diaz A; Jou E; Izquierdo C; Perez-Moreno MO; Moraga-Llop F; Olsina M; Vinado B; Sanfeliu E; Garcia A; Gonzalez-di Lauro S; Garcia-Garcia JJ; Dominguez A; Sa-Leao R; Muñoz-Almagro C; Microbiol Spectr; 2021 Dec; 9(3):e0115021. PubMed ID: 34878302 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Streptococcus pneumoniae serogroup 6 isolates from IPD in children and adults in Germany. van der Linden M; Winkel N; Küntzel S; Farkas A; Perniciaro SR; Reinert RR; Imöhl M PLoS One; 2013; 8(4):e60848. PubMed ID: 23593324 [TBL] [Abstract][Full Text] [Related]
10. Nationwide surveillance of paediatric invasive and non-invasive pneumococcal disease in Japan after the introduction of the 13-valent conjugated vaccine, 2015-2017. Nakano S; Fujisawa T; Ito Y; Chang B; Matsumura Y; Yamamoto M; Suga S; Ohnishi M; Nagao M Vaccine; 2020 Feb; 38(7):1818-1824. PubMed ID: 31882246 [TBL] [Abstract][Full Text] [Related]
11. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait. Mokaddas E; Albert MJ Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356 [TBL] [Abstract][Full Text] [Related]
12. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain. Muñoz-Almagro C; Ciruela P; Esteva C; Marco F; Navarro M; Bartolome R; Sauca G; Gallés C; Morta M; Ballester F; Raga X; Selva L; J Infect; 2011 Aug; 63(2):151-62. PubMed ID: 21679725 [TBL] [Abstract][Full Text] [Related]
13. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure. Camilli R; D'Ambrosio F; Del Grosso M; Pimentel de Araujo F; Caporali MG; Del Manso M; Gherardi G; D'Ancona F; Pantosti A; Vaccine; 2017 Aug; 35(35 Pt B):4587-4593. PubMed ID: 28716556 [TBL] [Abstract][Full Text] [Related]
14. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012. Lepoutre A; Varon E; Georges S; Dorléans F; Janoir C; Gutmann L; Lévy-Bruhl D; ; Vaccine; 2015 Jan; 33(2):359-66. PubMed ID: 25448105 [TBL] [Abstract][Full Text] [Related]
15. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014. Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682 [TBL] [Abstract][Full Text] [Related]
16. Serotype distribution and penicillin-non-susceptibility of Streptococcus pneumoniae causing invasive diseases in Kuwait: A 10-year study of impact of pneumococcal conjugate vaccines. Mokaddas E; Albert MJ Expert Rev Vaccines; 2016 Oct; 15(10):1337-45. PubMed ID: 27267070 [TBL] [Abstract][Full Text] [Related]
17. Pneumococcal serotype evolution in Western Europe. Tin Tin Htar M; Christopoulou D; Schmitt HJ BMC Infect Dis; 2015 Oct; 15():419. PubMed ID: 26468008 [TBL] [Abstract][Full Text] [Related]
18. Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany. Perniciaro S; Imöhl M; Fitzner C; van der Linden M PLoS One; 2019; 14(1):e0210278. PubMed ID: 30625215 [TBL] [Abstract][Full Text] [Related]
19. Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec. De Wals P; Lefebvre B; Deceuninck G; Longtin J Vaccine; 2018 Jan; 36(3):421-426. PubMed ID: 29224962 [TBL] [Abstract][Full Text] [Related]
20. The changing epidemiology of invasive pneumococcal disease after PCV13 vaccination in a country with intermediate vaccination coverage. Ciruela P; Izquierdo C; Broner S; Muñoz-Almagro C; Hernández S; Ardanuy C; Pallarés R; Domínguez A; Jané M; Vaccine; 2018 Nov; 36(50):7744-7752. PubMed ID: 30473132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]